FASTinov
FASTinov is a VC-backed company specializing in rapid Antimicrobial Susceptibility Testing (AST). Their disruptive, patented technology uses flow cytometry and proprietary fluorescent probes to detect bacterial lesions within minutes of antibiotic contact, delivering results in under 2 hours, significantly faster than the traditional 24-48 hours. This allows for optimal antibiotic treatment for life-threatening bacterial infections and helps combat antimicrobial resistance. Their product line includes CE-marked AST kits for Gram-Positive and Gram-Negative bacteria, along with the bioFAST software for data interpretation. The company is based in Porto, Portugal, and its technology is not yet FDA-cleared for sale in the U.S.
FASTinov
FASTinov is a VC-backed company specializing in rapid Antimicrobial Susceptibility Testing (AST). Their disruptive, patented technology uses flow cytometry and proprietary fluorescent probes to detect bacterial lesions within minutes of antibiotic contact, delivering results in under 2 hours, significantly faster than the traditional 24-48 hours. This allows for optimal antibiotic treatment for life-threatening bacterial infections and helps combat antimicrobial resistance. Their product line includes CE-marked AST kits for Gram-Positive and Gram-Negative bacteria, along with the bioFAST software for data interpretation. The company is based in Porto, Portugal, and its technology is not yet FDA-cleared for sale in the U.S.